Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07171684
NA

Single vs Multi-Dose Insulin for Glycemic Control (SUGAR)

Sponsor: Rutgers, The State University of New Jersey

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to see if diabetes in pregnancy can be treated with once daily dosing of insulin instead of once daily dosing plus insulin with meals. The main question this study aims to answer is: 1. Can a once daily dose of long-acting insulin control blood sugars as well as long-acting insulin plus meal-time insulin? 2. Do babies born to mothers who take one dose of long-acting insulin have more complications after birth than babies born to mothers who take long-acting and meal-time insulin? Researchers will compare one dose of long-acting insulin per day to this plus three doses of short-acting insulin with each meal to see if blood sugars are controlled. Participants will send their blood sugar logs to the study staff weekly, instead of to their OB/GYN, for adjustments to their insulin dosing.

Official title: Single vs Multi-Dose Insulin for Glycemic Control (SUGAR): A Randomized Noninferiority Trial

Key Details

Gender

FEMALE

Age Range

18 Years - 50 Years

Study Type

INTERVENTIONAL

Enrollment

176

Start Date

2025-11-26

Completion Date

2027-05-15

Last Updated

2025-12-04

Healthy Volunteers

No

Interventions

DRUG

Insulin glargine alone

Once daily dosing of insulin glargine

DRUG

Insulin glargine + insulin lispro

Once daily dosing of insulin glargine + three times daily dosing of insulin lispro with meals

Locations (1)

Robert Wood Johnson Univeristy Hospital

New Brunswick, New Jersey, United States